KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Other Non-Current Liabilities (2016 - 2025)

Precigen (PGEN) has disclosed Other Non-Current Liabilities for 13 consecutive years, with $134000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities fell 99.73% to $134000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $134000.0 through Dec 2025, down 99.73% year-over-year, with the annual reading at $134000.0 for FY2025, 99.73% down from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $134000.0 at Precigen, down from $78.6 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $83.0 million in Q1 2025, with the low at $50000.0 in Q2 2021.
  • Average Other Non-Current Liabilities over 4 years is $23.6 million, with a median of $100000.0 recorded in 2021.
  • The sharpest move saw Other Non-Current Liabilities plummeted 50.0% in 2021, then tumbled 99.73% in 2025.
  • Over 4 years, Other Non-Current Liabilities stood at $50000.0 in 2021, then changed by 0.0% to $50000.0 in 2022, then surged by 100974.0% to $50.5 million in 2024, then crashed by 99.73% to $134000.0 in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $134000.0, $78.6 million, and $83.0 million for Q4 2025, Q2 2025, and Q1 2025 respectively.